MIAMI, Dec. 14, 2015 /PRNewswire/ -- The North Shore-LIJ Health System and OPKO Health, Inc. (NYSE: OPK ) have formed a novel strategic alliance to provide genomic testing, molecular diagnostic testing and ancillary support services such as genetic counseling. The scope of testing will cover all genetic disorders, including prenatal screening, pediatric and postnatal diagnosis, assessing risk for inherited cancer, and testing for genetic cardiac abnormalities and neurological disorders. It will also include genetic analysis of cancer for sensitivity to drug therapies.